Simtra BioPharma Solutions has opened a new $250 million manufacturing facility in Bloomington, Indiana, expanding its capacity for sterile injectable drug production. The 150,000-square-foot building adds to the company’s existing 600,000-square-foot Bloomington campus and has generated approximately 450 jobs.
The facility is designed to support the development and manufacturing of sterile injectable medicines. Its equipment includes high-speed isolator-based syringe filling lines and multiple 30-square-meter lyophilizers for freeze-drying operations. The expansion increases Simtra’s manufacturing footprint as demand continues for specialized sterile drug production and injectable therapies.
Source: drug-dev.com · Image: Coldstream Sterile Manufacturing Facility by Coldstream01, CC0, via Wikimedia Commons
Use the database as your supply chain compass →
